Approximately 7,416 bottles of Nystatin Oral Suspension (100,000 units per mL) in Cherry/Peppermint flavor are being recalled because the medication was found to be subpotent during a routine 15-month test. This means the drug may not have the full strength required to effectively treat fungal infections as intended. If you are using this medication, contact your healthcare provider or pharmacist to discuss your treatment and obtain a replacement.
The medication is subpotent, meaning it contains less of the active ingredient than the label states. This can lead to ineffective treatment of fungal infections, potentially allowing the infection to persist or worsen.
Refund or replacement through pharmacy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.